Safe and Informed Use of Melatonin in Pediatric Patients

Melatonin—widely available over the counter and often perceived as “natural and safe”—has become increasingly used by caregivers to address sleep disturbances in children and adolescents, yet its proper role and safety profile in pediatrics remain nuanced and evolving. This course examines current evidence on indications such as insomnia and circadian rhythm sleep disorders, highlights concerns about unregulated supplement use and adverse effects, and reviews practical considerations for safe and informed use in pediatric patients. You will gain insight into how to support caregivers with balanced counseling, emphasize behavioral and environmental strategies, and apply clinical judgment when considering melatonin for sleep management in pediatric patients. Upon successful completion of this course, pharmacists should be able to: 1. Describe common pediatric indications and available evidence for melatonin use in children and adolescents. 2. Identify pharmacist considerations related to safety, dosing, behavioral counseling, and monitoring when melatonin is recommended or used in pediatric patients. Rachel Maynard, PharmD GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact Monica C Bogenschutz, PharmD, BCPS, BCPPS, DPLA, FPPA Pediatric Clinical Pharmacist Rachel Maynard and Monica Bogenschutz have no relevant financial relationships with ineligible companies to disclose. Course fee includes course materials and CPE credit submission to CPE Monitor. Course is non-refundable. Release Date: 5/25/2026 Planned Expiration Date: 5/25/2027 Recording, capturing, or sharing any part of this presentation is strictly prohibited. This includes the use of AI note-taking tools, audio/video devices, or screen capture technology. Please help us protect the privacy of our speakers and the integrity of the educational content. Copyright 2026, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden. Universal Activity Number (UAN): 0107-0000-26-222-H01-P Application-based CPE Activity Release Date: May 23, 2026 Planned Expiration Date: May 24, 2027 CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net. ¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.